beta

CXRX

Concordia International Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Concordia International Corp is a specialty pharmaceutical company which owns a diversified portfolio of branded and generic prescription products. It focuses on generic and legacy pharmaceutical products.

Market Cap: 39.1 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.concordiarx.com

Shares Outstanding: 51.3 Million

Float: 51.3 Million

Dividend: 0.0 (0.0%)

Beta: 0.553359

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 693 trading days

From: 2015-09-04 To: 2018-06-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud